Clinical Trial Update: Omega 3 FA Supplements as Augmentation in the Treatment of Depression [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial assessing omega-3 fatty acid supplements as augmentation in major depressive disorder; the study was terminated with posted results in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depression

Snippet

Sponsor: UConn Health | Conditions: Major Depression, Cancer | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2017-12-27